MANAGEMENT OF CPAP IN COVID PATIENTS WITH GRADE II HYPOXIA ACCORDING TO SIDDIQI

Manejo del CPAP en COVID-19 según SIDDIQI

Abstract

Introduction

There are alternatives to reduce hypoxia in patients infected with SARS COV 2 virus in stage II in the Siddiqi phases to minimize intubation and admission to the ICU, thus avoiding hospital saturation and increased complications and death.

Methodology

A bibliographic search was carried out between January and February 2024 based on scientific data: PubMed, SciELO, using the descriptors: “CPAP”, “Hypoxia”, “SARS COV2”, “Poscovid”, “continuous positive airway pressure”, “CPAP Ventilation”, “Airway Pressure Release Ventilatio”, “Respiratory therapy”, “artificial respiration”, “cardiopulmonary therapy”, “Organ Dysfunction”.

Results

Hypoxia represents a fundamental problem in COVID 19 patients, treatment with CPAP provides light and stable air pressure in the airways to keep them open, preventing their collapse, there is improvement in oxygenation in addition to reducing venous return. and cardiac output.

Conclusion

Articles about the CPAP were reviewed, verifying that they all support and endorse its use since it has no absolute contraindications, excellent results are achieved, it is easy to use and manage, in addition to being a non-invasive device.Keywords: CPAP, Hypoxia, SARS COV2 COVID-19.